Norway· NO-ID_173E14F3-1FF4-4D38-8AB3-CFA2B70726FA
Octaplex 1000 IE
A coagulation factor ix, ii, vii and x in combination product containing human coagulation factor ix + protein c + human coagulation factor vii + protein s + human coagulation factor ii + human coagulation factor x, registered in Norway by Octapharma (2). The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Coagulation factor ix, ii, vii and x in combination is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD01 (coagulation factor ix, ii, vii and x in combination), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Coagulation factor ix, ii, vii and x in combination · ATC B02BD01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Human Coagulation Factor Ix + Protein C + Human Coagulation Factor Vii + Protein S + Human Coagulation Factor Ii + Human Coagulation Factor X
- Manufacturer
- Octapharma (2)
- Country
- Norway (NO)
- ATC code
- B02BD01
- ATC class
- Coagulation factor IX, II, VII and X in combination
- Defined daily dose
- 1.6 TSD, E
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_173E14F3-1FF4-4D38-8AB3-CFA2B70726FA
- no_varenummer1169251NOK 5503
- gtin7340063612318
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for coagulation factor ix, ii, vii and x in combination.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor ix, ii, vii and x in combination · interactions on record
3 records
- 2 severe
- 1 moderate
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- PegvaliaseA16AB19moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Coagulation factor ix, ii, vii and x in combination in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenConfidex 1000 IE Pulver och vätska till injektionsvätska, lösningCSL Behring GmbH
- GermanyBeriplex P/NCsl Behring Gmbh
- United StatesBalfaxarOctapharma USA Inc
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Beriplex P/N, Cofact
- Belgium · Cofact, Confidex
- Bulgaria · Octaplex, Бериплекс P/N
- Cyprus · Beriplex P/N, Octaplex
- Czechia · Beriplex, Ocplex
- Germany · Beriplex P/N, Cofact
- Denmark · Confidex, Octaplex
- Estonia · Octaplex
- Spain · Beriplex, Cofact
- Finland · Cofact, Confidex
- France · Cofact, Confidex
- United Kingdom (Northern Ireland) · Beriplex P/N, Octaplex
- Greece · Beriplex P/N
- Croatia · Beriplex P/N, Octaplex
- Hungary · Beriplex P/N, Octaplex
- Ireland · Beriplex P/N, Octaplex Coagulation Factor Ix
- Iceland · Cofact, Octaplex
- Italy · Cofact, Confidex
- Lithuania · Octaplex
- Luxembourg · Cofact, Confidex
- Latvia · Octaplex
- Malta · Beriplex P/N, Octaplex
- Netherlands · Beriplex P/N, Cofact
- Poland · Beriplex P/N, Octaplex
- Portugal · Beriplex, Octaplex
- Romania · Beriplex P/N, Pronativ
- Sweden · Confidex, Ocplex
- Slovenia · Beriplex P/N, Octaplex
- Slovakia · Beriplex, Octaplex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4a0cc99-4eba-4405-b75f-1ff1ce900b75 GET /v1/drugs/d4a0cc99-4eba-4405-b75f-1ff1ce900b75?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og væske til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Koagulasjonsfaktor IX, II, VII og X i kombinasjon",
"merkevare_id": "ID_173E14F3-1FF4-4D38-8AB3-CFA2B70726FA",
"name_form_strength": "Octaplex 1000 IE pulv+væske til inf oppl",
"prescription_group": "C"
}See everything about coagulation factor ix, ii, vii and x in combination.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.